European Commission - Articles and news items

A strong EU IP framework guarantees future innovation for patients

Industry news / 19 May 2017 / European Federation of Pharmaceutical Industries and Associations (EFPIA)

Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for healthcare systems. With over 80 medicines approved every year – including some 30 new, approved substances – and over 7,000 medicines currently in development, […]

SMi group logo

12 months on: European Commission present updates on GDPR timelines and objectives at 7th annual BioBanking Industry Summit

Supplier news / 27 April 2017 / SMi Group

Legal advisor and policy analyst to provide opening keynote on the Impact of the General Data Protection Regulation (GDPR) on collaborative science in Europe…

EC approval for Lilly’s soft tissue sarcoma drug Olaratumab

Industry news / 18 November 2016 / Niamh Louise Marriott, Digital Content Producer

This conditional marketing authorisation is based on data from the Phase 2 portion of the pivotal JGDG trial and followed a positive recommendation from…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...